Match Document Document Title Score
US20170216320 ASPIRIN FORMULATION FOR INCREASED EFFICACY  
Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood clot in a subject in need thereof....
709
US20150072005 ASPIRIN FORMULATION FOR INCREASED EFFICACY  
Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood clot in a subject in need thereof....
706
4900559 Stabilized enteric coated aspirin granules and process of preparation  
A stabilized enteric coated aspirin granule product prepared by commingling the enteric coated aspirin granules with glutamic acid hydrochloride.
703
US20070049639 Aspirin-triggered lipid mediators  
Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
702
US20100216882 ASPIRIN-TRIGGERED LIPID MEDIATORS  
Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with diseases, including ischemia.
702
US20090149538 Aspirin-Triggered Lipid Mediators  
Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
702
3842170 SOLUBILIZED ASPIRIN   700
2890240 Aspirin crystallisation   700
US20150352129 ASPIRIN FORMULATION FOR INCREASED EFFICACY  
Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood clot in a subject in need thereof....
700
4228162 Dimethyl isosorbide in liquid formulation of aspirin  
A stabilized aspirin composition has been found which is comprised of acetylsalicylic acid and dimethyl isosorbide.
697
US20040235802 Combinations comprising cox-2-inhibitors and aspirin  
A pharmaceutical compsition is provided for treatment of conditions in mammals which are responsitive to COX-2 inhibition which comprises in combination a COX-2 inhibitor and low-dosa aspirin for...
697
4003999 Aspirin-tea coprecipitates for treating inflammation  
A novel coprecipitate of aspirin and tea is described. The coprecipitate is prepared by acidification of a solution of aspirin and tea. In vivo pharmacological evaluation of the coprecipitate...
696
US20140248352 CHEWABLE ENTERIC COATED ASPIRIN TABLETS  
The invention relates to a tablet capable of being chewed or disintegrated in the oral cavity, which comprises an enteric coated aspirin active ingredient, and preferably a lightly compressed...
693
US20150164818 SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR  
Described herein are an aspirin or active aspirin derivative and a COX-2 inhibitor, at least one of which has an enteric or partial enteric coating, administered in combination yet delivered...
691
4590183 Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin  
The method of providing cytoprotection of the gastric mucosa in a mammal receiving aspirin perorally which comprises orally administering either prior to or in combination with aspirin a...
682
US20190247304 TREATING INFLAMMATION WITH INHALED ASPIRIN  
The subject technology relates generally to pulmonary delivery of NSAIDs, such as aspirin.
678
US20030013688 Synergistic combination of pravastatin and aspirin and method  
A synergistic combination of pravastatin and aspirin is provided which is formed of 40 mg pravastatin and 81 mg or higher of aspirin, preferably 81 mg aspirin or 325 mg of aspirin. A method for...
676
US20050143354 Association of an antithrombotic and aspirin  
The present invention relates to a new combination of an antithrombotic and aspirin and to pharmaceutical compositions comprising them.
673
5157030 Rapidly soluble aspirin compositions and method  
The reaction rate between aspirin and an equimolar amount of alkaline compound in an aqueous medium is increased by the inclusion of a surface-active agent such as lecithin or an...
669
2134714 Saccharine-aspirin tablet  
The invention relates to a new medicated product, originally disclosed in my application Serial No. 13,318, filed March 27, 1935, of which this application is a continuation-in-part, having as its...
661
US20100210694 NEW NO-DONOR ASPIRIN DERIVATIVES  
The present invention refers to new NO-donors aspirin derivatives, a process for their preparation and pharmaceutical compositions containing them.
654
7618955 Association of an antithrombotic and aspirin  
The present invention relates to a new combination of an antithrombotic and aspirin and to pharmaceutical compositions comprising them.
650
10258562 Effervescent tablet containing high level of aspirin  
The present invention relates to a single-layer, effervescent tablet comprising a high level of aspirin and a reduced amount of alkaline substances, where the tablet rapidly dissolves in water.
650
US20160263015 EFFERVESCENT TABLET CONTAINING HIGH LEVEL OF ASPIRIN  
The present invention relates to a single-layer, effervescent tablet comprising a high level of aspirin and a reduced amount of alkaline substances, where the tablet rapidly dissolves in water.
647
US20070003615 Nanoparticulate clopidogrel and aspirin combination formulations  
The present invention is directed to compositions comprising a nanoparticulate clopidogrel and aspirin combination, or salts or derivatives thereof, having improved clopidogrel bioavailability....
641
9950987 Aspirin derivatives and uses thereof  
The present invention provides novel aspirin derivatives useful for preventing and/or treating cancer. The novel compounds of this invention may be particularly useful for the prevention and/or...
634
9850195 Aspirin derivatives and uses thereof  
The present invention provides novel aspirin derivatives useful for preventing and/or treating cancer. The novel compounds of this invention may be particularly useful for the prevention and/or...
634
9745248 Aspirin derivatives and uses thereof  
The present invention provides novel aspirin derivatives useful for preventing and/or treating cancer. The novel compounds of this invention may be particularly useful for the prevention and/or...
634
4375468 Constant order release aspirin composition and method of treating arthritis  
A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of a hydrogenated vegetable oil and from 0.5 to 7 weight percent of a saccharide selected from the group...
631
US20170112857 Extended Release Aspirin  
The present invention is directed to methods of inhibiting platelet aggregation, reducing serum thromboxane B2 levels, reducing systemic or cardiovascular inflammation, treating or preventing...
630
9187402 Aspirin derivatives and uses thereof  
The present invention provides novel aspirin derivatives useful for preventing and/or treating cancer. The novel compounds of this invention may be particularly useful for the prevention and/or...
630
5240917 Suppression of thromboxane levels by percutaneous administration of aspirin  
A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing...
628
US20060078611 Enteric coated aspirin granules comingled with binder  
The invention relates to a tablet capable of being chewed or disintegrated in the oral cavity, which comprises an enteric coated granule comprising an intimate mixture of an aspirin active...
627
4066756 Therapeutic compositions of 1,3-bis(2-carboxychromon-5-yloxyl)propan-2-ol and aspirin or indomethacin  
There is described a pharmaceutical mixture comprising 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol, or a pharmaceutically acceptable salt thereof, and aspirin or indomethacin. The mixture causes...
624
US20040115265 Multilayered tablet containing pravastatin and aspirin and method  
A multilayered tablet having three or more layers is provided which is useful for cholesterol lowering and reducing the risk of a myocardial infarction, which includes a first layer containing...
622
6071896 Suppression of thromboxane levels by percutaneous administration of aspirin  
A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing...
622
6268355 Stable aspirin-containing preparations for external use  
External preparations containing Aspirin which are stored for a long term and superior in dermal absorbability.The preparations are prepared by mixing Aspirin together with at least one substance...
620
8057820 Enteric coated aspirin granules comingled with binder  
The invention relates to a tablet capable of being chewed or disintegrated in the oral cavity, which comprises an enteric coated granule comprising an intimate mixture of an aspirin active...
620
US20080027032 COMBINATIONS COMPRISING COX-2 INHIBITORS AND ASPIRIN  
A pharmaceutical composition is provided for treatment of conditions in mammals which are responsive to COX-2 inhibition which comprises in combination a COX-2 inhibitor and low-dose aspirin for...
617
6512137 Synthesis method of nitroxymethylphenyl esters of aspirin derivatives  
The invention describes a method for the synthesis of nitroxymethylphenyl esters of aspirin derivatives.
610
US20130338120 Aspirin Derivatives and Uses Thereof  
The present invention provides novel aspirin derivatives useful for preventing and/or treating cancer. The novel compounds of this invention may be particularly useful for the prevention and/or...
609
5763425 Suppression of thromboxane levels by percutaneous administration of aspirin  
A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing...
607
US20170112858 Extended Release Aspirin  
The present invention is directed to methods of inhibiting platelet aggregation, reducing serum thromboxane B2 levels, reducing systemic or cardiovascular inflammation, treating or preventing...
607
US20140024681 COMPOUNDS WITH SUPER-ASPIRIN EFFECTS  
A compound having the structural formula (I) and pharmaceutically acceptable salt and/or hydrates thereof, (I) wherein Y is an arylester or an C1-C8 alkylaryl ester, selected from the group...
606
US20150291615 COMPOUNDS WITH SUPER-ASPIRIN EFFECTS  
A compound having the structural formula (I) and pharmaceutically acceptable salt and/or hydrates thereof, (I) wherein Y is an arylester or an C1-C8 alkylaryl ester, selected from the group...
606
US20180128811 ASPIRIN RESPONSE AND REACTIVITY TEST AND ASPIRIN COMPLIANCE TEST USING SYNTHETIC COLLAGEN  
The present invention provides platelet aggregation assays using synthetic collagen, methods of measuring a donor's platelet aspirin sensitivity status and residual platelet reactivity, and...
605
5389621 Method of enhancing the anticoagulant effects of aspirin using salicylamide  
A method of enhancing the anticoagulant effect of aspirin is disclosed, wherein salicylamide is coadministered. Salicylamide is essentially without anticoagulant effects of its own. A normal dose...
594
4049803 Augmentation of blood levels of aspirin  
The normal dosage of 10 grains (648 mg.) of aspirin, when combined with about 5 to 15, preferably about 10, grains of acetaminophen, yields increased blood levels of unhydrolyzed aspirin shortly...
587
6663896 Delayed release aspirin for vascular obstruction prophylaxis  
A method and controlled release oral unit dosage form of acetylsalicylic acid (aspirin) delays the release of the drug until a predetermined time interval after ingestion. This enables the drug to...
585
4885287 Novel method of administering aspirin and dosage forms containing same  
The invention relates to a novel method of administering aspirin to achieve improved delivery thereof. The invention further relates to novel dosage forms of neutralized aspirin adapted for nasal...
585


Search
« search again